General Information of Drug (ID: DMATPC1)

Drug Name
GEH-120714
Indication
Disease Entry ICD 11 Status REF
Multiple sclerosis 8A40 Phase 1 [1]
Cross-matching ID
TTD ID
D0DD4N

References

1 ClinicalTrials.gov (NCT01738347) Assess Safety, Bio-distribution, Dosimetry, and Optimize Imaging Protocol of GEH120714 (18F) Injection, in Healthy Volunteers and Participants With Relapsing and Remitting Multiple Sclerosis (rrMS). U.S. National Institutes of Health.